Lactoferricin Peptides Bind Bacterial LPS and Kill E. coli Through Membrane Disruption

Human and bovine lactoferricin-derived peptides bound bacterial LPS (the outer membrane component of gram-negative bacteria) and killed E. coli, with activity correlating with LPS binding strength.

Farnaud, Sebastien et al.·FEMS microbiology letters·2004·Preliminary Evidencein-vitro
RPEP-00912In VitroPreliminary Evidence2004RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Lactoferricin-derived peptides bound bacterial LPS and showed antimicrobial activity against E. coli including LPS mutant strains, with activity correlating with LPS binding — confirming membrane interaction as the killing mechanism.

Key Numbers

How They Did This

in-vitro study. Details in abstract.

Why This Research Matters

Advances understanding in antimicrobial-peptides, infection, receptor-signaling research.

The Bigger Picture

Contributes to the growing body of evidence in peptide research.

What This Study Doesn't Tell Us

See abstract for study-specific limitations.

Questions This Raises

  • ?Further research needed to confirm and extend findings.
  • ?Clinical translation potential to be evaluated.

Trust & Context

Key Stat:
Key finding Lactoferricin-derived peptides bound bacterial LPS and showed antimicrobial activity against E. coli including LPS mutant strains, with activity corre
Evidence Grade:
preliminary evidence from in-vitro study.
Study Age:
Published in 2004.
Original Title:
Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity.
Published In:
FEMS microbiology letters, 233(2), 193-9 (2004)
Database ID:
RPEP-00912

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

Lactoferricin Peptides Bind Bacterial LPS and Kill E. coli Through Membrane Disruption

What was found?

Human and bovine lactoferricin-derived peptides bound bacterial LPS (the outer membrane component of gram-negative bacteria) and killed E. coli, with activity correlating with LPS binding strength.

Read More on RethinkPeptides

Cite This Study

RPEP-00912·https://rethinkpeptides.com/research/RPEP-00912

APA

Farnaud, Sebastien; Spiller, Claire; Moriarty, Laura C; Patel, Alpesh; Gant, Vanya; Odell, Edward W; Evans, Robert W. (2004). Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity.. FEMS microbiology letters, 233(2), 193-9.

MLA

Farnaud, Sebastien, et al. "Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity.." FEMS microbiology letters, 2004.

RethinkPeptides

RethinkPeptides Research Database. "Interactions of lactoferricin-derived peptides with LPS and ..." RPEP-00912. Retrieved from https://rethinkpeptides.com/research/farnaud-2004-interactions-of-lactoferricinderived-peptides

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.